A Florida biopharmaceutical and diagnostics company is paying nearly $1.5 billion in stock for Elmwood Park-based diagnostics laboratory firm Bio-Reference Laboratories Inc.OPKO Health Inc. said ...

BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...

Elmwood Par, NJ, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA ...

Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...

BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today that it has received a letter from Horizon Blue Cross Blue Shield of New Jersey (Horizon) ...

Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...

When it comes to the healthcare sector, the Justice Department and the HHS-Office of Inspector General have no shortage of investigations and targets for prosecution. The more resources made available ...